Evidence map›Paper›PMID 37746796›Full record

ReviewClinical and translational allergy2023

Could it be hereditary angioedema?-Perspectives from different medical specialties.

Markus Magerl, Anna Sala-Cunill, Christina Weber-Chrysochoou, Susanne Trainotti, Ilaria Mormile, Giuseppe Spadaro

Open access · goldAbstract readReview
In one paragraph

Review in Clinical and translational allergy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 4 countries.

Markus MagerlInstitute of Allergology IFA, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Anna Sala-CunillAllergy Section, Internal Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Christina Weber-ChrysochoouAllergy Unit, Dermatology Department, University Hospital of Zurich, Zurich, Switzerland.
Susanne TrainottiDepartment of Otorhinolaryngology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Ilaria MormileDepartment of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy.ORCID https://orcid.org/0000-0001-7599-5426
Giuseppe SpadaroDepartment of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy.
University of Naples Federico II · ITFraunhofer Institute for Translational Medicine and Pharmacology · DETUM Klinikum · DEUniversity Hospital of Zurich · CHVall d'Hebron Hospital Universitari · ES

Funding

CSL Behring
6 · The paper itself

Abstract

Hereditary angioedema (HAE) is a rare autosomal dominant disease, with patients often suffering with associated symptoms for many years before receiving a correct diagnosis. The symptoms greatly impact a patient's quality of life (QoL) and include excruciating abdominal pain and angioedema of the skin and submucosa. Angioedema of the larynx represents a significant mortality risk in undiagnosed patients, and a large proportion of patients with HAE receive incorrect diagnoses and undergo unnecessary surgery. HAE-specific treatments can control and prevent acute life-threatening episodes, in addition to improving QoL, emphasizing the value of early diagnosis for patients. Diagnostic delay may be due to a lack of HAE awareness by healthcare professionals and the similarity of HAE symptoms with those of more common conditions, complicating differential diagnosis. The multifaceted nature of the condition may result in visits to one of many different medical settings, for example: the Emergency Room, pediatrics, general practice, otolaryngology, gastroenterology, and dermatology. Therefore, it is crucial that physicians in multiple healthcare specialties are aware of the disease to ensure that patients with HAE receive a timely diagnosis. Using patient cases from various medical specialties, this review highlights the necessity for cross-specialty awareness of HAE and outlines the essential information for the various healthcare professionals that may encounter a patient with HAE symptoms, in order to effectively treat and/or diagnose HAE.

Indexed as

bradykininC1-esterase inhibitordifferential diagnosishereditary angioedemarare disease

Identifiers

PMID37746796
PMCPMC10509412
OpenAlexW4386893726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.